6-methyl-2-ethyl-3-hydroxypyridine has been researched along with Heart Failure in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kalinina, EV; Lilitsa, GV; Zaslavskaia, RM | 1 |
| Rudyk, BI; Sabadyshin, RA | 2 |
3 other study(ies) available for 6-methyl-2-ethyl-3-hydroxypyridine and Heart Failure
| Article | Year |
|---|---|
[Efficacy of emoxypine in combined therapy for elderly patients with postinfarct cardiosclerosis and heart failure].
Topics: Adrenergic beta-Antagonists; Aged; Coronary Artery Disease; Diuretics; Drug Therapy, Combination; Echocardiography, Doppler; Electrocardiography, Ambulatory; Female; Fibrinolytic Agents; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Myocardial Infarction; Picolines; Platelet Aggregation Inhibitors; Vasodilator Agents | 2004 |
[The significance of the antioxidant properties of emoxipin in the combined treatment of patients with chronic heart failure].
Topics: Adult; Aged; Antioxidants; Chronic Disease; Drug Evaluation; Drug Therapy, Combination; Female; Heart Failure; Humans; Lipid Peroxidation; Male; Middle Aged; Picolines | 1992 |
[Effects of emoxipine on lipid peroxidation in patients with chronic heart failure].
Topics: Adult; Antioxidants; Female; Heart Failure; Humans; Lipid Peroxidation; Male; Middle Aged; Picolines | 1991 |